URSODIOL

URSODIOL was reported 22312 times

URSODIOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CFTR GENE MUTATION 19 0.7600
1 BILE ACIDS INCREASED 39 0.2203
2 RESPIRATORY TRACT MALFORMATION 28 0.2105
3 PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA 15 0.1562
4 PULMONARY MALFORMATION 42 0.1197
5 BILIARY CIRRHOSIS 22 0.1095
6 BLOOD ALKALINE PHOSPHATASE ABNORMAL 81 0.0900
7 HAEMOSIDEROSIS 24 0.0896
8 VENOOCCLUSIVE DISEASE 191 0.0762
9 CHOLESTASIS OF PREGNANCY 35 0.0761
10 PRIMARY BILIARY CHOLANGITIS 35 0.0745
11 PARENTERAL NUTRITION 16 0.0693
12 LUNG CYST 27 0.0687
13 BILIARY CIRRHOSIS PRIMARY 22 0.0636
14 VENOOCCLUSIVE LIVER DISEASE 295 0.0597
15 HEPATIC NEOPLASM MALIGNANT 120 0.0566
16 CHOLANGITIS SCLEROSING 100 0.0486
17 DEVICE RELATED BACTERAEMIA 15 0.0484
18 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 43 0.0482
19 VANISHING BILE DUCT SYNDROME 51 0.0457
20 LACTATION DISORDER 22 0.0452
21 PORTAL HYPERTENSIVE GASTROPATHY 25 0.0443
22 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 239 0.0439
23 APLASTIC ANAEMIA 229 0.0438
24 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 26 0.0433
25 POOR SUCKING REFLEX 17 0.0428
26 COMPLICATIONS OF TRANSPLANTED LIVER 14 0.0389
27 BILIARY TRACT INFECTION 24 0.0386
28 DISSEMINATED ASPERGILLOSIS 18 0.0381
29 BILE DUCT STENOSIS 43 0.0359
30 CHOLANGITIS ACUTE 25 0.0331
31 ASPARTATE AMINOTRANSFERASE ABNORMAL 48 0.0315
32 ACUTE GRAFT VERSUS HOST DISEASE 132 0.0288
33 ENGRAFTMENT SYNDROME 17 0.0288
34 LYMPHOCYTE STIMULATION TEST POSITIVE 23 0.0287
35 ENTEROCOCCAL SEPSIS 23 0.0284
36 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 78 0.0282
37 HEPATORENAL SYNDROME 46 0.0272
38 PORTAL HYPERTENSION 84 0.0272
39 GRAFT VERSUS HOST DISEASE IN LIVER 19 0.0265
40 CYSTIC FIBROSIS 146 0.0263
41 HYPERTONIA NEONATAL 14 0.0262
42 LIP PRURITUS 22 0.0257
43 CHOLANGITIS 156 0.0251
44 IRON OVERLOAD 27 0.0250
45 OESOPHAGEAL ACHALASIA 16 0.0248
46 PANCREATITIS RELAPSING 20 0.0244
47 PSEUDOMONAS TEST POSITIVE 20 0.0244
48 VARICES OESOPHAGEAL 73 0.0241
49 LIVER TRANSPLANT REJECTION 43 0.0239
50 LIVER TRANSPLANT 87 0.0239
51 ALLERGIC SINUSITIS 20 0.0233
52 HEPATIC FIBROSIS 77 0.0224
53 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 31 0.0219
54 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 15 0.0209
55 GRAFT VERSUS HOST DISEASE 148 0.0206
56 CHOLANGIOCARCINOMA 30 0.0201
57 HEPATIC ENCEPHALOPATHY 185 0.0198
58 BILE DUCT STONE 61 0.0192
59 OESOPHAGEAL VARICES HAEMORRHAGE 39 0.0179
60 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 38 0.0178
61 POUCHITIS 15 0.0174
62 BILIARY TRACT DISORDER 24 0.0173
63 AXONAL NEUROPATHY 15 0.0172
64 BLOOD AMYLASE INCREASED 29 0.0169
65 KLEBSIELLA BACTERAEMIA 16 0.0168
66 CYTOMEGALOVIRUS TEST POSITIVE 30 0.0168
67 HEPATIC INFECTION 21 0.0164
68 ALANINE AMINOTRANSFERASE ABNORMAL 34 0.0161
69 VASCULAR DEVICE INFECTION 73 0.0161
70 CHRONIC GRAFT VERSUS HOST DISEASE 58 0.0160
71 GALLBLADDER ENLARGEMENT 17 0.0158
72 METASTASES TO SKIN 16 0.0155
73 GRAFT VERSUS HOST DISEASE IN SKIN 34 0.0154
74 BILIRUBIN CONJUGATED INCREASED 36 0.0154
75 PLATELET TRANSFUSION 19 0.0148
76 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 38 0.0147
77 PNEUMONIA CYTOMEGALOVIRAL 28 0.0144
78 BLOOD BILIRUBIN INCREASED 384 0.0142
79 BILIARY OBSTRUCTION 18 0.0139
80 HYPERURICAEMIA 56 0.0136
81 BLOOD ALKALINE PHOSPHATASE INCREASED 333 0.0134
82 BLOOD BILIRUBIN ABNORMAL 17 0.0133
83 PULMONARY FUNCTION TEST DECREASED 58 0.0132
84 ESCHERICHIA BACTERAEMIA 31 0.0132
85 LIVER ABSCESS 42 0.0129
86 HYPERBILIRUBINAEMIA 131 0.0126
87 ASCITES 370 0.0126
88 HEPATIC FAILURE 371 0.0123
89 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 16 0.0121
90 STEROID DIABETES 18 0.0120
91 HEPATIC CIRRHOSIS 224 0.0119
92 MUCOSAL INFLAMMATION 309 0.0118
93 ADENOVIRUS INFECTION 34 0.0117
94 HYPOALBUMINAEMIA 90 0.0116
95 EXPOSURE VIA BREAST MILK 46 0.0115
96 HEPATIC PAIN 49 0.0115
97 IMMUNE-MEDIATED HEPATIC DISORDER 22 0.0113
98 HEPATIC FUNCTION ABNORMAL 419 0.0112
99 AUTOIMMUNE HEPATITIS 78 0.0112
100 PNEUMONIA STAPHYLOCOCCAL 22 0.0111
101 CAPILLARY LEAK SYNDROME 23 0.0111
102 MATERNAL EXPOSURE DURING BREAST FEEDING 45 0.0111
103 BONE MARROW TRANSPLANT 21 0.0111
104 PORTAL VEIN THROMBOSIS 35 0.0108
105 CYTOMEGALOVIRUS INFECTION REACTIVATION 47 0.0106
106 AMMONIA INCREASED 54 0.0106
107 CYTOMEGALOVIRUS VIRAEMIA 47 0.0106
108 GASTROENTERITIS NOROVIRUS 14 0.0105
109 PRE-ECLAMPSIA 50 0.0105
110 KIDNEY FIBROSIS 18 0.0104
111 POLYMYOSITIS 18 0.0102
112 BLOOD LOSS ANAEMIA 23 0.0101
113 BILE DUCT OBSTRUCTION 19 0.0100
114 CYSTITIS HAEMORRHAGIC 40 0.0099
115 IMMUNE-MEDIATED HEPATITIS 20 0.0098
116 ACUTE MYELOID LEUKAEMIA RECURRENT 21 0.0098
117 SPUTUM INCREASED 21 0.0097
118 CHOLESTASIS 183 0.0095
119 BILIARY DILATATION 14 0.0095
120 HEPATITIS TOXIC 24 0.0092
121 STEM CELL TRANSPLANT 23 0.0092
122 GAMMA-GLUTAMYLTRANSFERASE INCREASED 204 0.0092
123 PARAINFLUENZAE VIRUS INFECTION 14 0.0092
124 JAUNDICE CHOLESTATIC 32 0.0090
125 HEPATOSPLENOMEGALY 23 0.0090
126 INTRA-ABDOMINAL FLUID COLLECTION 16 0.0089
127 STAPHYLOCOCCAL SEPSIS 44 0.0089
128 JAUNDICE 239 0.0089
129 HEPATIC MASS 17 0.0088
130 BLOOD ALBUMIN DECREASED 70 0.0088
131 NORMAL NEWBORN 47 0.0086
132 LIVER DISORDER 382 0.0086
133 OCULAR ICTERUS 37 0.0085
134 CHOLESTATIC LIVER INJURY 19 0.0085
135 HEPATIC NECROSIS 32 0.0085
136 THROMBOTIC MICROANGIOPATHY 82 0.0084
137 HYPERPHOSPHATAEMIA 18 0.0084
138 DISSEMINATED INTRAVASCULAR COAGULATION 117 0.0083
139 HYPERAMMONAEMIA 41 0.0082
140 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 27 0.0082
141 PSEUDOMEMBRANOUS COLITIS 18 0.0081
142 HUMAN HERPESVIRUS 6 INFECTION 15 0.0079
143 ASPARTATE AMINOTRANSFERASE INCREASED 420 0.0079
144 MULTIPLE ORGAN DYSFUNCTION SYNDROME 223 0.0079
145 SERUM FERRITIN INCREASED 41 0.0078
146 VARICELLA ZOSTER VIRUS INFECTION 16 0.0077
147 BK VIRUS INFECTION 26 0.0077
148 LUNG TRANSPLANT 27 0.0076
149 PSEUDOMONAS INFECTION 65 0.0076
150 DEVICE RELATED SEPSIS 15 0.0074
151 HEPATOMEGALY 73 0.0074
152 ACUTE LYMPHOCYTIC LEUKAEMIA 21 0.0074
153 FORCED EXPIRATORY VOLUME DECREASED 21 0.0074
154 ALANINE AMINOTRANSFERASE INCREASED 451 0.0073
155 PANCREATIC CYST 14 0.0073
156 CYTOKINE RELEASE SYNDROME 147 0.0073
157 FAECAL CALPROTECTIN INCREASED 23 0.0073
158 HEPATIC ENZYME ABNORMAL 36 0.0072
159 SYSTEMIC CANDIDA 18 0.0072
160 PROCTITIS 20 0.0071
161 PNEUMONIA FUNGAL 28 0.0071
162 HEPATITIS FULMINANT 21 0.0071
163 CHOLECYSTITIS ACUTE 40 0.0071
164 FEBRILE NEUTROPENIA 465 0.0070
165 BACTERAEMIA 83 0.0070
166 TRANSPLANT FAILURE 17 0.0069
167 GASTROINTESTINAL ULCER 15 0.0068
168 FAECES PALE 15 0.0067
169 SPLENOMEGALY 79 0.0067
170 CYTOMEGALOVIRUS INFECTION 106 0.0064
171 ABDOMINAL MASS 17 0.0063
172 BLOOD CULTURE POSITIVE 19 0.0063
173 DRUG-INDUCED LIVER INJURY 199 0.0063
174 BLOOD LACTATE DEHYDROGENASE INCREASED 100 0.0063
175 ASPERGILLUS INFECTION 41 0.0062
176 HYPOPHOSPHATAEMIA 46 0.0062
177 PHYSICAL DECONDITIONING 16 0.0062
178 ENTEROCOCCAL INFECTION 30 0.0062
179 HEPATIC CYTOLYSIS 79 0.0062
180 TOXIC EPIDERMAL NECROLYSIS 94 0.0062
181 HAEMATOLOGICAL INFECTION 15 0.0061
182 HISTIOCYTOSIS HAEMATOPHAGIC 18 0.0061
183 ORGANISING PNEUMONIA 30 0.0060
184 TRANSFUSION 63 0.0060
185 IMMUNE-MEDIATED ENTEROCOLITIS 22 0.0060
186 STAPHYLOCOCCAL BACTERAEMIA 26 0.0060
187 PNEUMONIA VIRAL 19 0.0060
188 PULMONARY HAEMORRHAGE 46 0.0059
189 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 56 0.0059
190 CYTOPENIA 70 0.0057
191 ENTEROCOLITIS 33 0.0057
192 HYPERVOLAEMIA 28 0.0057
193 STEATORRHOEA 15 0.0056
194 HEPATITIS ACUTE 36 0.0055
195 ACUTE RESPIRATORY DISTRESS SYNDROME 97 0.0055
196 HEPATITIS CHOLESTATIC 33 0.0055
197 NOCARDIOSIS 14 0.0055
198 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 126 0.0054
199 SEPTIC SHOCK 235 0.0054
200 RHINOVIRUS INFECTION 21 0.0054
201 IRON DEFICIENCY 24 0.0053
202 HAEMOLYSIS 41 0.0053
203 IRON DEFICIENCY ANAEMIA 49 0.0053
204 HEPATOCELLULAR CARCINOMA 40 0.0053
205 LIVER FUNCTION TEST INCREASED 111 0.0052
206 BRONCHOPULMONARY ASPERGILLOSIS 40 0.0052
207 ENTERITIS 33 0.0052
208 LOW BIRTH WEIGHT BABY 40 0.0050
209 PREMATURE DELIVERY 80 0.0050
210 INTERSTITIAL LUNG DISEASE 243 0.0050
211 ESCHERICHIA INFECTION 41 0.0050
212 BLOOD UREA INCREASED 83 0.0050
213 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 29 0.0049
214 MULTI-ORGAN FAILURE 84 0.0049
215 BLOOD URIC ACID INCREASED 28 0.0048
216 PROCTALGIA 31 0.0048
217 CHOLELITHIASIS 158 0.0048
218 HYPERNATRAEMIA 24 0.0048
219 PREMATURE BABY 144 0.0048
220 PNEUMOCYSTIS JIROVECII PNEUMONIA 48 0.0048
221 PANCREATITIS ACUTE 106 0.0047
222 B-CELL LYMPHOMA 16 0.0047
223 CARDIAC FAILURE CHRONIC 20 0.0047
224 DUODENAL ULCER 33 0.0047
225 TRANSAMINASES INCREASED 104 0.0047
226 INTRACRANIAL PRESSURE INCREASED 26 0.0047
227 MALNUTRITION 52 0.0046
228 ABNORMAL FAECES 38 0.0046
229 HYPOMAGNESAEMIA 64 0.0046
230 FIBROSIS 14 0.0045
231 BRONCHIOLITIS 16 0.0045
232 DIASTOLIC DYSFUNCTION 14 0.0045
233 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 34 0.0045
234 BLOOD MAGNESIUM DECREASED 39 0.0045
235 HEPATITIS 115 0.0045
236 BLOOD CREATININE DECREASED 14 0.0045
237 PNEUMONIA BACTERIAL 41 0.0045
238 FOETAL GROWTH RESTRICTION 27 0.0044
239 SHOCK HAEMORRHAGIC 36 0.0044
240 NON-SMALL CELL LUNG CANCER 21 0.0044
241 BLOOD PHOSPHORUS DECREASED 16 0.0044
242 AUTOIMMUNE HAEMOLYTIC ANAEMIA 15 0.0044
243 RESPIRATORY SYNCYTIAL VIRUS INFECTION 38 0.0044
244 DRUG LEVEL BELOW THERAPEUTIC 24 0.0043
245 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22 0.0043
246 NEPHROGENIC ANAEMIA 20 0.0043
247 PULMONARY ALVEOLAR HAEMORRHAGE 24 0.0043
248 CHEILITIS 23 0.0042
249 PLATELET COUNT DECREASED 452 0.0042
250 SKIN PAPILLOMA 17 0.0042
251 NEUTROPHIL COUNT DECREASED 171 0.0042
252 ERYTHEMA MULTIFORME 39 0.0042
253 CLOSTRIDIUM DIFFICILE COLITIS 44 0.0041
254 ATELECTASIS 40 0.0041
255 CHOLECYSTITIS 49 0.0041
256 VITAMIN D DEFICIENCY 40 0.0041
257 TUMOUR LYSIS SYNDROME 36 0.0041
258 ENCEPHALOPATHY 100 0.0041
259 SEPSIS 454 0.0041
260 APLASIA PURE RED CELL 14 0.0041
261 PANCYTOPENIA 227 0.0041
262 PLEURAL EFFUSION 247 0.0041
263 CARDIAC FAILURE ACUTE 27 0.0040
264 ACUTE MYELOID LEUKAEMIA 63 0.0040
265 DRUG LEVEL DECREASED 41 0.0040
266 AZOTAEMIA 16 0.0040
267 PERICARDIAL EFFUSION 92 0.0040
268 HEPATIC ENZYME INCREASED 271 0.0040
269 RHINITIS 32 0.0040
270 LYMPHOCYTE COUNT DECREASED 70 0.0040
271 KLEBSIELLA INFECTION 20 0.0040
272 ARTHRITIS BACTERIAL 16 0.0039
273 POST-TRAUMATIC STRESS DISORDER 26 0.0039
274 APHTHOUS ULCER 30 0.0039
275 BACTERIAL INFECTION 72 0.0039
276 PLATELET COUNT ABNORMAL 23 0.0038
277 INSURANCE ISSUE 58 0.0038
278 COAGULOPATHY 63 0.0038
279 DERMATITIS ACNEIFORM 23 0.0038
280 ESCHERICHIA URINARY TRACT INFECTION 16 0.0038
281 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 19 0.0037
282 COMPRESSION FRACTURE 20 0.0037
283 FAECES SOFT 27 0.0037
284 AGRANULOCYTOSIS 69 0.0037
285 GASTROINTESTINAL INFLAMMATION 29 0.0037
286 CACHEXIA 19 0.0037
287 PROTHROMBIN TIME PROLONGED 22 0.0037
288 HEPATITIS B 22 0.0036
289 ACUTE RESPIRATORY FAILURE 70 0.0036
290 YELLOW SKIN 17 0.0036
291 FOOD ALLERGY 28 0.0036
292 ENCEPHALITIS 25 0.0036
293 ILEUS PARALYTIC 16 0.0036
294 DRUG ERUPTION 63 0.0036
295 TOXIC ENCEPHALOPATHY 18 0.0035
296 URINE OUTPUT DECREASED 31 0.0035
297 PURPURA 31 0.0035
298 HEPATOTOXICITY 78 0.0035
299 DISEASE COMPLICATION 16 0.0035
300 TRANSPLANT REJECTION 28 0.0035
301 HAEMORRHOIDAL HAEMORRHAGE 17 0.0035
302 EOSINOPHIL COUNT INCREASED 29 0.0035
303 LOCALISED OEDEMA 16 0.0035
304 RESPIRATORY FAILURE 252 0.0035
305 PRURITUS 1326 0.0034
306 PARTIAL SEIZURES 18 0.0034
307 GASTROENTERITIS 50 0.0034
308 RIGHT VENTRICULAR FAILURE 24 0.0034
309 GASTRIC ULCER 65 0.0034
310 HYPERTRIGLYCERIDAEMIA 20 0.0034
311 FREQUENT BOWEL MOVEMENTS 92 0.0034
312 WRONG PRODUCT ADMINISTERED 23 0.0034
313 HAEMATEMESIS 86 0.0034
314 HYPOXIA 119 0.0034
315 ADRENAL INSUFFICIENCY 41 0.0034
316 DEVICE RELATED INFECTION 52 0.0034
317 COLECTOMY 19 0.0034
318 GESTATIONAL DIABETES 16 0.0034
319 GASTROINTESTINAL INFECTION 30 0.0033
320 SMALL INTESTINAL OBSTRUCTION 41 0.0033
321 SUSPECTED OFF LABEL USE 15 0.0033
322 HYPOKALAEMIA 153 0.0033
323 GENERALISED OEDEMA 41 0.0033
324 THROMBOCYTOPENIA 370 0.0033
325 STOMATITIS 200 0.0033
326 NEPHROPATHY TOXIC 37 0.0033
327 ACUTE HEPATIC FAILURE 45 0.0033
328 HYPOTHYROIDISM 105 0.0033
329 MELAENA 72 0.0033
330 BOWEL MOVEMENT IRREGULARITY 25 0.0033
331 CLOSTRIDIUM DIFFICILE INFECTION 71 0.0032
332 SUBARACHNOID HAEMORRHAGE 33 0.0032
333 HEPATIC LESION 14 0.0032
334 RENAL IMPAIRMENT 270 0.0032
335 HYDRONEPHROSIS 24 0.0032
336 AUTOIMMUNE DISORDER 31 0.0032
337 IMMUNOSUPPRESSION 28 0.0032
338 HYPERTRANSAMINASAEMIA 22 0.0032
339 BLOOD CREATINE INCREASED 14 0.0032
340 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 32 0.0031
341 PULMONARY TOXICITY 22 0.0031
342 CHROMATURIA 70 0.0031
343 LIVER FUNCTION TEST ABNORMAL 90 0.0031
344 MALABSORPTION 16 0.0031
345 NEPHROTIC SYNDROME 21 0.0031
346 OLIGURIA 19 0.0031
347 TUBULOINTERSTITIAL NEPHRITIS 57 0.0030
348 UPPER GASTROINTESTINAL HAEMORRHAGE 51 0.0030
349 MATERNAL EXPOSURE DURING PREGNANCY 270 0.0030
350 GASTROINTESTINAL SOUNDS ABNORMAL 15 0.0030
351 RENAL CYST 24 0.0030
352 ABDOMINAL TENDERNESS 15 0.0030
353 TACHYPNOEA 41 0.0030
354 MAJOR DEPRESSION 22 0.0030
355 LIPASE INCREASED 23 0.0030
356 MOUTH HAEMORRHAGE 22 0.0030
357 ATRIAL SEPTAL DEFECT 25 0.0030
358 ILEUS 37 0.0030
359 BRONCHIECTASIS 20 0.0030
360 HEPATIC STEATOSIS 55 0.0029
361 PYREXIA 1019 0.0029
362 HYPERGLYCAEMIA 107 0.0029
363 COLITIS ULCERATIVE 131 0.0029
364 GALLBLADDER DISORDER 52 0.0029
365 PRODUCT DISTRIBUTION ISSUE 27 0.0029
366 ALTERED STATE OF CONSCIOUSNESS 63 0.0029
367 RED BLOOD CELL COUNT DECREASED 83 0.0029
368 MYOSITIS 26 0.0029
369 BLOOD POTASSIUM INCREASED 47 0.0029
370 FAILURE TO THRIVE 15 0.0029
371 C-REACTIVE PROTEIN INCREASED 105 0.0029
372 FLANK PAIN 27 0.0029
373 INFUSION SITE ERYTHEMA 24 0.0028
374 CHOLECYSTITIS CHRONIC 19 0.0028
375 BLOOD CREATININE INCREASED 185 0.0028
376 HAEMOPTYSIS 79 0.0028
377 PREMATURE LABOUR 16 0.0028
378 HAEMATOCRIT DECREASED 56 0.0028
379 ACUTE KIDNEY INJURY 432 0.0028
380 STAPHYLOCOCCAL INFECTION 93 0.0028
381 ANAEMIA 536 0.0028
382 CHOLECYSTECTOMY 32 0.0028
383 HYPOCALCAEMIA 53 0.0028
384 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17 0.0028
385 GINGIVITIS 15 0.0028
386 RENAL FAILURE ACUTE 118 0.0028
387 BLOOD CREATINE PHOSPHOKINASE INCREASED 80 0.0028
388 RALES 16 0.0028
389 ELECTROLYTE IMBALANCE 32 0.0028
390 LIVER INJURY 67 0.0027
391 RESPIRATORY DISTRESS 75 0.0027
392 PROTEINURIA 51 0.0027
393 FLUID OVERLOAD 39 0.0027
394 WEIGHT FLUCTUATION 28 0.0027
395 FAECES DISCOLOURED 58 0.0027
396 WHITE BLOOD CELL COUNT DECREASED 289 0.0027
397 WHITE BLOOD CELL COUNT ABNORMAL 17 0.0027
398 TYPE 1 DIABETES MELLITUS 16 0.0027
399 OESOPHAGITIS 29 0.0027
400 SCRATCH 28 0.0027
401 ABDOMINAL DISTENSION 276 0.0026
402 THERAPY INTERRUPTED 188 0.0026
403 FOETAL EXPOSURE DURING PREGNANCY 213 0.0026
404 HAEMODIALYSIS 22 0.0026
405 SKIN ATROPHY 15 0.0026
406 LARGE INTESTINE POLYP 18 0.0026
407 PNEUMOTHORAX 41 0.0026
408 CEREBRAL HAEMORRHAGE 92 0.0026
409 APPENDICITIS 24 0.0026
410 DIARRHOEA HAEMORRHAGIC 24 0.0026
411 MITRAL VALVE INCOMPETENCE 29 0.0026
412 EPSTEIN-BARR VIRUS INFECTION 16 0.0026
413 MENTAL STATUS CHANGES 71 0.0026
414 RENAL TUBULAR NECROSIS 25 0.0025
415 PULMONARY HYPERTENSION 53 0.0025
416 SPINAL COMPRESSION FRACTURE 21 0.0025
417 THERAPY CESSATION 130 0.0025
418 POSTOPERATIVE WOUND INFECTION 17 0.0025
419 RENAL FAILURE 332 0.0025
420 HEPATITIS C 30 0.0025
421 HAEMOGLOBIN DECREASED 255 0.0025
422 INGUINAL HERNIA 15 0.0025
423 HERPES SIMPLEX 16 0.0025
424 BONE MARROW FAILURE 50 0.0025
425 PNEUMONIA 793 0.0024
426 LARGE INTESTINE PERFORATION 17 0.0024
427 LOWER GASTROINTESTINAL HAEMORRHAGE 18 0.0024
428 EXPOSURE DURING PREGNANCY 151 0.0024
429 ABDOMINAL PAIN 565 0.0024
430 NEUTROPENIA 330 0.0024
431 THERAPY NON-RESPONDER 109 0.0024
432 PYELONEPHRITIS 21 0.0024
433 BLOOD TEST ABNORMAL 34 0.0024
434 PULMONARY ARTERIAL HYPERTENSION 35 0.0024
435 PNEUMONIA ASPIRATION 60 0.0024
436 DECREASED APPETITE 557 0.0024
437 SINUS TACHYCARDIA 34 0.0024
438 TRICUSPID VALVE INCOMPETENCE 19 0.0024
439 COVID-19 PNEUMONIA 28 0.0024
440 TASTE DISORDER 48 0.0024
441 FULL BLOOD COUNT ABNORMAL 25 0.0024
442 INTESTINAL OBSTRUCTION 89 0.0024
443 MYOCARDITIS 27 0.0024
444 ACIDOSIS 18 0.0024
445 PRODUCT PRESCRIBING ERROR 56 0.0023
446 MATERNAL DRUGS AFFECTING FOETUS 18 0.0023
447 NEUROTOXICITY 41 0.0023
448 METASTASES TO LUNG 27 0.0023
449 HAEMOGLOBIN ABNORMAL 15 0.0023
450 ANURIA 20 0.0023
451 CAESAREAN SECTION 27 0.0023
452 INFECTION 335 0.0023
453 PETECHIAE 24 0.0023
454 PNEUMONITIS 62 0.0023
455 PULMONARY CONGESTION 30 0.0023
456 BLOOD IRON DECREASED 27 0.0023
457 DEPRESSED LEVEL OF CONSCIOUSNESS 90 0.0023
458 CONCOMITANT DISEASE AGGRAVATED 14 0.0023
459 HYPONATRAEMIA 127 0.0023
460 VIRAL INFECTION 75 0.0023
461 HYPERKALAEMIA 79 0.0023
462 STEVENS-JOHNSON SYNDROME 50 0.0022
463 END STAGE RENAL DISEASE 41 0.0022
464 DRUG LEVEL INCREASED 37 0.0022
465 HAEMOLYTIC ANAEMIA 20 0.0022
466 VASCULITIS 26 0.0022
467 METASTASES TO LYMPH NODES 15 0.0022
468 INABILITY TO AFFORD MEDICATION 22 0.0022
469 OEDEMA PERIPHERAL 270 0.0022
470 BODY TEMPERATURE INCREASED 45 0.0022
471 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 121 0.0022
472 RHABDOMYOLYSIS 91 0.0022
473 GASTROINTESTINAL HAEMORRHAGE 182 0.0022
474 PRODUCT ADMINISTRATION ERROR 44 0.0022
475 RESPIRATION ABNORMAL 15 0.0022
476 BLOOD SODIUM DECREASED 41 0.0022
477 SHOCK 50 0.0022
478 EATING DISORDER 46 0.0022
479 URINARY RETENTION 72 0.0022
480 OEDEMA 117 0.0022
481 ORAL PAIN 48 0.0021
482 HYPOGAMMAGLOBULINAEMIA 14 0.0021
483 PAPULE 15 0.0021
484 CEREBRAL INFARCTION 52 0.0021
485 ORAL CANDIDIASIS 28 0.0021
486 RENAL DISORDER 99 0.0021
487 PEMPHIGOID 16 0.0021
488 NEPHROLITHIASIS 97 0.0021
489 RETINAL HAEMORRHAGE 15 0.0021
490 HYPERCALCAEMIA 26 0.0021
491 METASTASES TO LIVER 37 0.0021
492 OFF LABEL USE 1843 0.0021
493 GASTROENTERITIS VIRAL 38 0.0021
494 HAEMATOCHEZIA 116 0.0021
495 INTERNAL HAEMORRHAGE 24 0.0021
496 FUNGAL INFECTION 70 0.0021
497 COLITIS 79 0.0021
498 PRURITUS GENERALISED 45 0.0021
499 HOSPITALISATION 319 0.0021
500 CANDIDA INFECTION 35 0.0021
501 HICCUPS 17 0.0021
502 PLATELET COUNT INCREASED 27 0.0021
503 LABORATORY TEST ABNORMAL 61 0.0021
504 EPISTAXIS 154 0.0021
505 PELVIC FRACTURE 16 0.0021
506 THERAPY PARTIAL RESPONDER 32 0.0020
507 DYSPNOEA EXERTIONAL 77 0.0020
508 INTERNATIONAL NORMALISED RATIO INCREASED 58 0.0020
509 WHITE BLOOD CELL COUNT INCREASED 78 0.0020
510 PULMONARY OEDEMA 91 0.0020
511 SUBDURAL HAEMATOMA 29 0.0020
512 HOSPICE CARE 20 0.0020
513 DIARRHOEA 1284 0.0020
514 INCONTINENCE 21 0.0020
515 SUPRAVENTRICULAR TACHYCARDIA 19 0.0020
516 POST PROCEDURAL COMPLICATION 38 0.0020
517 SKIN HYPERPIGMENTATION 17 0.0020
518 POST PROCEDURAL HAEMORRHAGE 23 0.0020
519 PRODUCTIVE COUGH 94 0.0020
520 MYOPATHY 17 0.0020
521 CELLULITIS 99 0.0020
522 CARDIAC FAILURE 157 0.0020
523 ANOREXIA 25 0.0019
524 MYELODYSPLASTIC SYNDROME 28 0.0019
525 THERAPY CHANGE 19 0.0019
526 BLOOD POTASSIUM DECREASED 58 0.0019
527 SCAB 22 0.0019
528 NEPHROPATHY 18 0.0019
529 FLUID RETENTION 98 0.0019
530 LUNG INFILTRATION 17 0.0019
531 DISEASE PROGRESSION 227 0.0019
532 CONSTIPATION 418 0.0019
533 GASTRIC HAEMORRHAGE 22 0.0019
534 DELIRIUM 66 0.0019
535 BRAIN OEDEMA 24 0.0019
536 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21 0.0019
537 ANAL INCONTINENCE 17 0.0019
538 ABDOMINAL PAIN UPPER 387 0.0019
539 DEHYDRATION 250 0.0019
540 MUSCULOSKELETAL CHEST PAIN 29 0.0019
541 GLOMERULAR FILTRATION RATE DECREASED 23 0.0019
542 CARDIOMEGALY 23 0.0019
543 SKIN LESION 51 0.0019
544 METABOLIC ACIDOSIS 59 0.0018
545 HYPOPHAGIA 47 0.0018
546 POOR VENOUS ACCESS 19 0.0018
547 NOCTURIA 22 0.0018
548 MYELOSUPPRESSION 65 0.0018
549 MOUTH ULCERATION 38 0.0018
550 LUNG INFECTION 28 0.0018
551 RASH MACULO-PAPULAR 40 0.0018
552 PANCREATITIS 95 0.0018
553 LIVE BIRTH 15 0.0018
554 FULL BLOOD COUNT DECREASED 36 0.0018
555 INFUSION SITE PAIN 23 0.0018
556 ORTHOSTATIC HYPOTENSION 31 0.0018
557 OSTEOPENIA 27 0.0018
558 RESPIRATORY DISORDER 53 0.0018
559 LIP DRY 16 0.0018
560 IMPAIRED GASTRIC EMPTYING 24 0.0018
561 INFLUENZA 196 0.0018
562 HYPERLIPIDAEMIA 21 0.0018
563 ATRIAL FLUTTER 14 0.0018
564 HAEMATURIA 60 0.0018
565 SKIN LACERATION 19 0.0017
566 BLOOD PRESSURE DECREASED 116 0.0017
567 DRUG INTERACTION 276 0.0017
568 ASPIRATION 19 0.0017
569 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
570 BODY TEMPERATURE DECREASED 17 0.0017
571 NO THERAPEUTIC RESPONSE 21 0.0017
572 ULCER 27 0.0017
573 SEASONAL ALLERGY 24 0.0017
574 LEUKAEMIA 16 0.0017
575 LYMPHADENOPATHY 60 0.0017
576 FLATULENCE 96 0.0017
577 BLOOD PRESSURE SYSTOLIC INCREASED 33 0.0017
578 ORAL HERPES 33 0.0017
579 OXYGEN SATURATION DECREASED 95 0.0017
580 GASTROINTESTINAL DISORDER 150 0.0017
581 MUSCLE ATROPHY 21 0.0017
582 EAR INFECTION 44 0.0017
583 GENERAL PHYSICAL HEALTH DETERIORATION 191 0.0016
584 WEIGHT DECREASED 460 0.0016
585 BONE PAIN 96 0.0016
586 BLOOD URINE PRESENT 31 0.0016
587 LUNG DISORDER 80 0.0016
588 FEEDING DISORDER 33 0.0016
589 HYPOGLYCAEMIA 78 0.0016
590 NEURALGIA 39 0.0016
591 BLOOD CALCIUM INCREASED 14 0.0016
592 PHOTOPHOBIA 30 0.0016
593 HYPERTHYROIDISM 23 0.0016
594 TOXIC SKIN ERUPTION 16 0.0016
595 BLOOD TRIGLYCERIDES INCREASED 28 0.0016
596 BLOOD COUNT ABNORMAL 24 0.0016
597 PRODUCT AVAILABILITY ISSUE 36 0.0016
598 COUGH 443 0.0016
599 HYPERTENSION 333 0.0016
600 COVID-19 275 0.0016
601 SINUS DISORDER 31 0.0016
602 DRY EYE 78 0.0016
603 GASTRITIS 41 0.0016
604 SINUS BRADYCARDIA 15 0.0016
605 HERNIA 30 0.0015
606 HYPOTENSION 311 0.0015
607 PULMONARY MASS 23 0.0015
608 LUPUS-LIKE SYNDROME 14 0.0015
609 IMMUNODEFICIENCY 23 0.0015
610 FACE OEDEMA 26 0.0015
611 GINGIVAL BLEEDING 21 0.0015
612 HAEMORRHOIDS 30 0.0015
613 DENTAL CARIES 17 0.0015
614 RECTAL HAEMORRHAGE 66 0.0015
615 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 73 0.0015
616 VOMITING 714 0.0015
617 INTENTIONAL PRODUCT USE ISSUE 133 0.0015
618 SECRETION DISCHARGE 19 0.0015
619 HERPES ZOSTER 87 0.0015
620 FISTULA 17 0.0015
621 WEIGHT INCREASED 337 0.0015
622 MIDDLE INSOMNIA 28 0.0015
623 PREGNANCY 30 0.0015
624 DISORIENTATION 59 0.0015
625 DRUG RESISTANCE 38 0.0015
626 URINARY TRACT INFECTION 252 0.0015
627 CONDITION AGGRAVATED 448 0.0015
628 SKIN ULCER 38 0.0015
629 DIABETES MELLITUS 112 0.0015
630 HALLUCINATION, VISUAL 31 0.0015
631 CIRCULATORY COLLAPSE 25 0.0015
632 HAEMATOMA 38 0.0015
633 PERIPHERAL COLDNESS 20 0.0015
634 PHARYNGITIS 18 0.0014
635 FATIGUE 1129 0.0014
636 INFUSION RELATED REACTION 96 0.0014
637 DIZZINESS POSTURAL 14 0.0014
638 OBESITY 23 0.0014
639 IMMUNE SYSTEM DISORDER 19 0.0014
640 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
641 OROPHARYNGEAL PAIN 133 0.0014
642 ANAPHYLACTIC SHOCK 37 0.0014
643 ECZEMA 75 0.0014
644 CHILLS 167 0.0014
645 ABDOMINAL PAIN LOWER 36 0.0014
646 BLOOD CALCIUM DECREASED 16 0.0014
647 DRUG WITHDRAWAL SYNDROME NEONATAL 21 0.0014
648 INCREASED APPETITE 27 0.0014
649 DIALYSIS 20 0.0014
650 BLOOD GLUCOSE ABNORMAL 26 0.0014
651 ASTHENIA 527 0.0014
652 CONJUNCTIVITIS 26 0.0014
653 RHINORRHOEA 90 0.0014
654 NEUROPATHY PERIPHERAL 132 0.0014
655 PHARYNGITIS STREPTOCOCCAL 15 0.0014
656 ABDOMINAL DISCOMFORT 232 0.0014
657 RESPIRATORY TRACT INFECTION 36 0.0014
658 NAUSEA 1093 0.0014
659 DRY MOUTH 112 0.0014
660 BLOOD PRESSURE INCREASED 211 0.0014
661 GASTROOESOPHAGEAL REFLUX DISEASE 111 0.0014
662 PRODUCT DOSE OMISSION 90 0.0014
663 PULMONARY THROMBOSIS 15 0.0014
664 BLOOD PRESSURE FLUCTUATION 33 0.0014
665 DIVERTICULITIS 38 0.0014
666 EOSINOPHILIA 24 0.0014
667 NEUTROPHIL COUNT INCREASED 14 0.0014
668 TOOTH EXTRACTION 17 0.0014
669 RASH PRURITIC 74 0.0014
670 INITIAL INSOMNIA 14 0.0014
671 HEAD DISCOMFORT 24 0.0014
672 CARDIOMYOPATHY 20 0.0014
673 VENTRICULAR FIBRILLATION 15 0.0013
674 PRODUCT DOSE OMISSION ISSUE 396 0.0013
675 ATRIAL FIBRILLATION 131 0.0013
676 ERUCTATION 26 0.0013
677 BRAIN FOG 21 0.0013
678 OSTEOPOROSIS 55 0.0013
679 INTESTINAL PERFORATION 15 0.0013
680 REBOUND EFFECT 15 0.0013
681 NEOPLASM PROGRESSION 46 0.0013
682 RASH 576 0.0013
683 ANAPHYLACTIC REACTION 73 0.0013
684 UPPER RESPIRATORY TRACT INFECTION 61 0.0013
685 HIATUS HERNIA 17 0.0013
686 CARDIAC ARREST 108 0.0013
687 CONFUSIONAL STATE 211 0.0013
688 LETHARGY 75 0.0013
689 SLEEP DISORDER 92 0.0013
690 DISEASE RECURRENCE 62 0.0013
691 DECREASED ACTIVITY 14 0.0013
692 TREATMENT NONCOMPLIANCE 71 0.0013
693 CYSTITIS 41 0.0013
694 HIP FRACTURE 41 0.0013
695 CYANOSIS 20 0.0013
696 PRODUCT DOSE OMISSION IN ERROR 36 0.0013
697 HAEMORRHAGE INTRACRANIAL 19 0.0013
698 CONTUSION 122 0.0013
699 DYSPHONIA 74 0.0013
700 LEUKOPENIA 63 0.0013
701 RASH ERYTHEMATOUS 60 0.0013
702 DYSPEPSIA 123 0.0012
703 TACHYCARDIA 111 0.0012
704 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
705 MALIGNANT NEOPLASM PROGRESSION 127 0.0012
706 CHEST DISCOMFORT 126 0.0012
707 INTENTIONAL DOSE OMISSION 35 0.0012
708 DYSPHAGIA 116 0.0012
709 ILLNESS 125 0.0012
710 DEVICE OCCLUSION 17 0.0012
711 HAEMORRHAGE 126 0.0012
712 UPPER LIMB FRACTURE 24 0.0012
713 PRESCRIBED UNDERDOSE 24 0.0012
714 PRODUCT USE IN UNAPPROVED INDICATION 298 0.0012
715 BLOOD CHOLESTEROL INCREASED 56 0.0012
716 INFLAMMATION 62 0.0012
717 POLLAKIURIA 50 0.0012
718 SPINAL FRACTURE 24 0.0012
719 PRODUCT USE ISSUE 225 0.0012
720 SKIN DISCOLOURATION 55 0.0012
721 PRESYNCOPE 29 0.0012
722 COLD SWEAT 21 0.0012
723 CARDIOGENIC SHOCK 17 0.0012
724 EAR PAIN 23 0.0012
725 PERIPHERAL SWELLING 182 0.0012
726 INSOMNIA 312 0.0012
727 CHRONIC KIDNEY DISEASE 89 0.0012
728 HEART RATE DECREASED 41 0.0012
729 BRONCHITIS 86 0.0012
730 LEUKOCYTOSIS 21 0.0012
731 OSTEOMYELITIS 21 0.0012
732 PERITONITIS 24 0.0012
733 BRADYCARDIA 61 0.0011
734 NASOPHARYNGITIS 212 0.0011
735 MASS 16 0.0011
736 MALAISE 502 0.0011
737 CARPAL TUNNEL SYNDROME 16 0.0011
738 DYSARTHRIA 43 0.0011
739 MYALGIA 194 0.0011
740 DYSURIA 42 0.0011
741 SOMNOLENCE 229 0.0011
742 LYMPHOPENIA 16 0.0011
743 HEPATOCELLULAR INJURY 16 0.0011
744 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29 0.0011
745 JOINT RANGE OF MOTION DECREASED 15 0.0011
746 CHEST PAIN 206 0.0011
747 MUSCULAR WEAKNESS 126 0.0011
748 BACK PAIN 256 0.0011
749 COMPLICATION ASSOCIATED WITH DEVICE 16 0.0011
750 LYMPHOMA 17 0.0011
751 ARTHRALGIA 457 0.0011
752 ARRHYTHMIA 52 0.0011
753 PAIN IN JAW 31 0.0011
754 EJECTION FRACTION DECREASED 17 0.0011
755 BASAL CELL CARCINOMA 17 0.0011
756 ANGIOEDEMA 48 0.0011
757 ELECTROCARDIOGRAM QT PROLONGED 39 0.0011
758 CONVULSION 62 0.0011
759 HYPERSOMNIA 31 0.0011
760 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
761 CARDIO-RESPIRATORY ARREST 45 0.0011
762 APHONIA 15 0.0011
763 DYSPNOEA 608 0.0011
764 TYPE 2 DIABETES MELLITUS 36 0.0011
765 THROMBOSIS 86 0.0011
766 BEDRIDDEN 14 0.0011
767 FALL 354 0.0011
768 TOXICITY TO VARIOUS AGENTS 179 0.0011
769 RESPIRATORY ARREST 29 0.0011
770 LACTIC ACIDOSIS 34 0.0010
771 BONE DISORDER 19 0.0010
772 LOWER LIMB FRACTURE 20 0.0010
773 DIZZINESS 519 0.0010
774 HEART RATE INCREASED 103 0.0010
775 OSTEOARTHRITIS 44 0.0010
776 METASTASES TO BONE 17 0.0010
777 SINUSITIS 106 0.0010
778 HEADACHE 647 0.0010
779 TREMOR 171 0.0010
780 DYSSTASIA 30 0.0010
781 SKIN FISSURES 20 0.0010
782 SKIN DISORDER 34 0.0010
783 PRODUCT USE COMPLAINT 16 0.0010
784 CARDIAC FAILURE CONGESTIVE 81 0.0010
785 BLOOD PRESSURE ABNORMAL 20 0.0010
786 GOUT 18 0.0010
787 FOOT FRACTURE 19 0.0010
788 DEMENTIA 28 0.0010
789 ALOPECIA 196 0.0010
790 DRUG INTOLERANCE 96 0.0010
791 SCAR 17 0.0010
792 LOCALISED INFECTION 24 0.0010
793 PALLOR 27 0.0010
794 SURGERY 58 0.0010
795 RIB FRACTURE 20 0.0010
796 NASAL CONGESTION 57 0.0010
797 VENTRICULAR TACHYCARDIA 16 0.0010
798 NIGHT SWEATS 31 0.0010
799 APHASIA 29 0.0010
800 PULMONARY EMBOLISM 91 0.0010
801 RESTLESSNESS 35 0.0010
802 DEEP VEIN THROMBOSIS 62 0.0010
803 RESPIRATORY TRACT CONGESTION 15 0.0009
804 RASH PAPULAR 21 0.0009
805 LOSS OF CONSCIOUSNESS 120 0.0009
806 FEMUR FRACTURE 29 0.0009
807 SPEECH DISORDER 49 0.0009
808 POOR QUALITY SLEEP 20 0.0009
809 ABORTION SPONTANEOUS 37 0.0009
810 LIMB INJURY 25 0.0009
811 SYNCOPE 92 0.0009
812 DEPRESSION 209 0.0009
813 KIDNEY INFECTION 18 0.0009
814 EPILEPSY 28 0.0009
815 ARTHRITIS 72 0.0009
816 MANIA 15 0.0009
817 SEIZURE 105 0.0009
818 RENAL INJURY 27 0.0009
819 ABNORMAL BEHAVIOUR 36 0.0009
820 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 163 0.0009
821 EYE PAIN 51 0.0009
822 DIABETES MELLITUS INADEQUATE CONTROL 16 0.0009
823 ASTHMA 102 0.0009
824 THIRST 16 0.0009
825 ANXIETY 254 0.0009
826 RETCHING 19 0.0009
827 PALPITATIONS 104 0.0009
828 DIPLOPIA 23 0.0009
829 HEMIPARESIS 15 0.0009
830 NEOPLASM MALIGNANT 59 0.0009
831 ABSCESS 14 0.0009
832 PRODUCT PRESCRIBING ISSUE 19 0.0009
833 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
834 ADVERSE DRUG REACTION 78 0.0009
835 BALANCE DISORDER 75 0.0009
836 DERMATITIS 18 0.0009
837 PAIN IN EXTREMITY 253 0.0009
838 HEAD INJURY 27 0.0009
839 DEATH 731 0.0008
840 URINARY INCONTINENCE 25 0.0008
841 DEAFNESS 22 0.0008
842 IRRITABLE BOWEL SYNDROME 18 0.0008
843 NERVOUS SYSTEM DISORDER 26 0.0008
844 HEPATIC CANCER 20 0.0008
845 AMNESIA 54 0.0008
846 PROCEDURAL PAIN 23 0.0008
847 GAIT DISTURBANCE 158 0.0008
848 MUSCLE SPASMS 151 0.0008
849 ERYTHEMA 168 0.0008
850 SYSTEMIC LUPUS ERYTHEMATOSUS 29 0.0008
851 GAIT INABILITY 27 0.0008
852 CATARACT 48 0.0008
853 AGEUSIA 20 0.0008
854 CRYING 29 0.0008
855 FLUSHING 81 0.0008
856 DRY SKIN 106 0.0008
857 ILL-DEFINED DISORDER 48 0.0008
858 SKIN CANCER 17 0.0008
859 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 56 0.0008
860 MEMORY IMPAIRMENT 108 0.0008
861 DEPRESSED MOOD 41 0.0008
862 BLISTER 43 0.0008
863 AGITATION 56 0.0008
864 URTICARIA 127 0.0008
865 PAIN 465 0.0008
866 FEELING ABNORMAL 181 0.0008
867 VERTIGO 46 0.0008
868 DISCOMFORT 46 0.0008
869 WOUND 21 0.0008
870 DRUG INEFFECTIVE 987 0.0007
871 TREATMENT FAILURE 62 0.0007
872 LOWER RESPIRATORY TRACT INFECTION 34 0.0007
873 ACUTE MYOCARDIAL INFARCTION 22 0.0007
874 EYE PRURITUS 25 0.0007
875 RASH MACULAR 26 0.0007
876 HYPERSENSITIVITY 137 0.0007
877 MUSCLE TWITCHING 17 0.0007
878 THROAT IRRITATION 33 0.0007
879 BLOOD GLUCOSE DECREASED 35 0.0007
880 UNEVALUABLE EVENT 55 0.0007
881 SWELLING 68 0.0007
882 MUSCULOSKELETAL PAIN 38 0.0007
883 WHEEZING 43 0.0007
884 DRUG DOSE OMISSION 119 0.0007
885 MUSCULOSKELETAL STIFFNESS 63 0.0007
886 TINNITUS 33 0.0007
887 FEELING HOT 44 0.0007
888 HALLUCINATION 54 0.0007
889 BLOOD GLUCOSE INCREASED 135 0.0007
890 COMA 34 0.0007
891 MENTAL DISORDER 31 0.0007
892 HYPOAESTHESIA 106 0.0007
893 HEART RATE IRREGULAR 16 0.0007
894 SWELLING FACE 46 0.0007
895 THROAT TIGHTNESS 19 0.0007
896 INJECTION SITE PRURITUS 47 0.0007
897 IMPAIRED HEALING 23 0.0007
898 GASTRIC DISORDER 24 0.0007
899 ANGINA PECTORIS 20 0.0007
900 NECK PAIN 39 0.0007
901 JOINT SWELLING 84 0.0007
902 EYE IRRITATION 40 0.0007
903 JOINT STIFFNESS 18 0.0007
904 ACCIDENTAL OVERDOSE 25 0.0007
905 FEELING COLD 19 0.0007
906 ANGER 23 0.0007
907 UNDERDOSE 49 0.0007
908 GASTRIC CANCER 17 0.0007
909 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35 0.0007
910 INFLUENZA LIKE ILLNESS 55 0.0007
911 MENTAL IMPAIRMENT 16 0.0007
912 MOOD SWINGS 21 0.0007
913 FIBROMYALGIA 16 0.0007
914 RASH GENERALISED 17 0.0007
915 JOINT INJURY 14 0.0007
916 VISUAL IMPAIRMENT 81 0.0007
917 THERAPEUTIC RESPONSE DECREASED 39 0.0006
918 THERAPEUTIC RESPONSE SHORTENED 21 0.0006
919 VISUAL ACUITY REDUCED 21 0.0006
920 MOOD ALTERED 17 0.0006
921 UNRESPONSIVE TO STIMULI 16 0.0006
922 MIGRAINE 59 0.0006
923 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
924 NERVOUSNESS 32 0.0006
925 HYPOACUSIS 26 0.0006
926 THERAPEUTIC PRODUCT EFFECT DECREASED 27 0.0006
927 MOBILITY DECREASED 43 0.0006
928 LACRIMATION INCREASED 18 0.0006
929 SKIN EXFOLIATION 50 0.0006
930 OCULAR HYPERAEMIA 28 0.0006
931 PLASMA CELL MYELOMA 23 0.0006
932 AGGRESSION 29 0.0006
933 COGNITIVE DISORDER 27 0.0006
934 EYE DISORDER 19 0.0006
935 DISTURBANCE IN ATTENTION 31 0.0006
936 RHEUMATOID ARTHRITIS 65 0.0006
937 LIP SWELLING 19 0.0006
938 DYSGEUSIA 42 0.0006
939 BLINDNESS 23 0.0006
940 ROAD TRAFFIC ACCIDENT 23 0.0005
941 PANIC ATTACK 20 0.0005
942 VISION BLURRED 75 0.0005
943 HYPERHIDROSIS 70 0.0005
944 BURNING SENSATION 38 0.0005
945 PARAESTHESIA 84 0.0005
946 DRUG EXPOSURE DURING PREGNANCY 18 0.0005
947 DYSKINESIA 21 0.0005
948 INJURY 36 0.0005
949 CARDIAC DISORDER 46 0.0005
950 ADVERSE EVENT 45 0.0005
951 ACNE 37 0.0005
952 OSTEONECROSIS 16 0.0005
953 VAGINAL HAEMORRHAGE 21 0.0005
954 INJECTION SITE ERYTHEMA 60 0.0005
955 IRRITABILITY 29 0.0005
956 CEREBROVASCULAR ACCIDENT 81 0.0005
957 MYOCARDIAL INFARCTION 83 0.0005
958 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
959 MOVEMENT DISORDER 15 0.0005
960 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
961 EYE SWELLING 17 0.0005
962 LIMB DISCOMFORT 14 0.0005
963 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
964 INTENTIONAL PRODUCT MISUSE 38 0.0004
965 INJECTION SITE MASS 16 0.0004
966 MEDICATION ERROR 24 0.0004
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30 0.0004
968 LUNG NEOPLASM MALIGNANT 17 0.0004
969 HOT FLUSH 31 0.0004
970 SUICIDAL IDEATION 36 0.0004
971 INCORRECT DOSE ADMINISTERED 86 0.0004
972 INJECTION SITE HAEMORRHAGE 30 0.0004
973 PSORIASIS 49 0.0004
974 DERMATITIS ATOPIC 19 0.0004
975 INJECTION SITE PAIN 109 0.0004
976 PRODUCT SUBSTITUTION ISSUE 20 0.0003
977 DEVICE MALFUNCTION 24 0.0003
978 INJECTION SITE BRUISING 26 0.0003
979 ARTHROPATHY 18 0.0003
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 65 0.0003
981 DRUG EFFECT DECREASED 17 0.0003
982 NO ADVERSE EVENT 56 0.0003
983 INJECTION SITE SWELLING 22 0.0003
984 OVERDOSE 60 0.0003
985 INJECTION SITE REACTION 18 0.0003
986 EMOTIONAL DISTRESS 31 0.0003
987 DEVICE ISSUE 21 0.0002
988 SKIN BURNING SENSATION 16 0.0002
989 PRODUCT QUALITY ISSUE 30 0.0002
990 PROSTATE CANCER 15 0.0002
991 BREAST CANCER 17 0.0002
992 DRUG WITHDRAWAL SYNDROME 14 0.0002
993 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002